Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across multiple cancer ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• IDOV-Immune (IDOV-Immune)

Snippet

Sponsor: ViroMissile, Inc. | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 1 | Status: RECRUITING